Cormorant Asset Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.03M | Sell |
|
|||||
|
2023
Q4 | $2.91M | Hold |
|
|||||
|
2023
Q3 | $2.01M | Hold |
|
|||||
|
2023
Q2 | $3.54M | Hold |
|
|||||
|
2023
Q1 | $3.17M | Sell |
|
|||||
|
2022
Q4 | $30.4M | Buy |
|
|||||
|
2022
Q3 | $16.8M | Buy |
|
|||||
|
2022
Q2 | $5.81M | Hold |
|
|||||
|
2022
Q1 | $10.2M | Buy |
|
|||||
|
2021
Q4 | $33M | Sell |
|
|||||
|
2021
Q3 | $53.5M | Sell |
|
|||||
|
2021
Q2 | $82.7M | Sell |
|
|||||
|
2021
Q1 | $110M | Sell |
|
|||||
|
2020
Q4 | $75.4M | Buy |
|